By UGA Biopharma…
To get in touch with UGA Biopharma GmbH, simply fill out the form below.
Subscribe to Supplier
UGA Biopharma to present fast-track cell line development at virtual CPhI Festival
Hennigsdorf, Germany: UGA Biopharma GmbH, the specialist contract developer of biologic and biosimilar cell lines, will participate in the virtual CPhI Festival of Pharma over eleven days in October, replacing that month’s normal CPhI Worldwide expo, scheduled for Milan.
The CPhI Festival will take the form of a combination of online webinars and networking platforms, with UGA using the latter to find new customers and partner companies among the sizeable community interested in high performance cell lines with titers from 4 to 7 g/L for the production of biologics.
Accelerated biologics production
UGA will use the session to showcase its fast track Cell Line Development service for biologics and biosimilars, accompanied by its proprietary First CHOice® cell culture media and feeds, which can be used to boost the production of for example therapeutic antibodies, bispecific antibodies, fusion proteins, enzymes and hormones.
UGA CEO Dr. Lars Kober and Business Development Manager Dr. Marcel Nowak will be available throughout the festival to explain key differentiations and advantages for high titer production, quality, fast timelines, high biosimilarity, traceability and UGA’s proven track record.
About UGA Biopharma
UGA Biopharma GmbH is an experienced contract developer of biologics and biosimilars with the capabilities to handle all necessary steps from cell line development and bioprocess development to the development of purification strategies and appropriate analytics.
The company supplies its customers in Germany and abroad from its headquarter in Hennigsdorf, near Berlin. Several clients have used UGA products in clinical trials or in products that have received market authorization.
UGA Biopharma GmbH CRO activities are centered on cell line development for biologics and biosimilars, specializing in the development of stable expressing CHO cell lines and cell media for the production of biologics and biosimilars for biopharmaceutical companies. Typical clients are biopharma manufacturers, research institutions (like universities and research institutes) as well as start-ups and other CROs that need to outsource CLD, upstream, and/or downstream processing.
UGA’s mission is to fulfill customer requests, recognizing industry needs for high titer, high quality and fast delivery timelines, along with robust CHO cell lines. To this end, UGA can deliver cell lines, reaching titers from 4 to 7 g/L, within four months of receiving the originator sequence.
UGA has also developed its proprietary First CHOice® cell culture media and feeds platform to boost the productivity of cell lines. Furthermore, UGA Biopharma GmbH offers ready-to-use biosimilar cell lines, which allow clients interested in biosimilar development fast track access to a highly biosimilar cell line.
Further information at: www.ugabiopharma.com
About CPhI Festival of Pharma 2020
Now in its 31st year, CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing. CPhI Worldwide 2020 was originally planned as a three-day event opening October 13 at the Fiero Milano expo center in Milan, Italy, to include the co-located zoned exhibitions; ICSE Outsourcing, P-MEC Machinery and Equipment, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and events and the new BioProduction.
However, during June 2020, the CPhI events team from leading global B2B Events organizer and publisher Informa Markets decided that the global scale of the event combined with the social distancing required to combat COVID-19 required the postponement of CPhI Worldwide to autumn 2021.
To replace the Milan event, Informa will stage the 2020 CPhI Festival of Pharma as the world’s largest pharmaceutical virtual meeting, using online technologies to create a networking platform that will combine the world’s leading pharma companies, eminent speakers and extensive networking opportunities.
Further information at: https://www.cphi.com/europe/en/about/news-and-updates/event-postponed-new-pharma-festival.html
Click on UGA Biosimilar Development for detailed service information.